PCSK9 inhibition in PAD

被引：4
|
作者：
Huynh, Karina
机构：
来源：
NATURE REVIEWS CARDIOLOGY | 2018年 / 15卷 / 01期
关键词：
D O I：
10.1038/nrcardio.2017.204
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4 / 5
页数：1
相关论文
共 50 条
  • [21] PCSK9 inhibition in the management of familial hypercholesterolemia
    Ogura, Masatsune
    JOURNAL OF CARDIOLOGY, 2018, 71 (1-2) : 1 - 7
  • [22] Lipoprotein(a) and PCSK9 inhibition: clinical evidence
    Ruscica, Massimiliano
    Greco, Maria Francesca
    Ferri, Nicola
    Corsini, Alberto
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0L) : L53 - L56
  • [23] Lipoprotein (a), arterial inflammation, and PCSK9 inhibition
    Tardif, Jean-Claude
    Rheaume, Eric
    Rhainds, David
    Dube, Marie-Pierre
    EUROPEAN HEART JOURNAL, 2019, 40 (33) : 2782 - 2784
  • [24] PCSK9 inhibition to reduce cardiovascular disease risk: recent findings from the biology of PCSK9
    Tavori, Hagai
    Giunzioni, Ilaria
    Fazio, Sergio
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2015, 22 (02) : 126 - 132
  • [25] PCSK9 Inhibition in Atherosclerotic Cardiovascular Disease
    Delialis, Dimitrios
    Dimopoulou, Maria-Angeliki
    Papaioannou, Maria
    Kotsira, Georgia
    Maneta, Eleni
    Mavraganis, Georgios
    Loutos, Christos
    Georgiopoulos, Georgios
    Stamatelopoulos, Kimon
    CURRENT PHARMACEUTICAL DESIGN, 2023, 29 (23) : 1802 - 1824
  • [26] PCSK9 inhibition and the global diabetes epidemic
    Luca Mascitelli
    Mark R. Goldstein
    Diabetologia, 2017, 60 : 751 - 752
  • [27] Genetic Inhibition of PCSK9 and Liver Function
    Rimbert, Antoine
    Smati, Sarra
    Dijk, Wieneke
    Le May, Cedric
    Cariou, Bertrand
    JAMA CARDIOLOGY, 2021, 6 (03) : 353 - 354
  • [28] PCSK9 inhibition for autosomal recessive hypercholesterolemia
    Chemello, Kevin
    Martin, Cesar
    Lambert, Gilles
    ATHEROSCLEROSIS, 2019, 284 : 209 - 211
  • [29] The evolving landscape of PCSK9 inhibition in cancer
    Oza, Palak P.
    Kashfi, Khosrow
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 949
  • [30] PCSK9 inhibition and type 2 diabetes
    Lotta, Luca A.
    Griffin, Simon J.
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (12): : 926 - 927
12345